New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) - modified release granules - 60.12 mg - active: pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) excipient: cetyl alcohol dimeticone hypromellose phthalate macrogol 4000 triethyl citrate - for treatment of conditions associated with pancreatic exocrine insufficiency, such as: cystic fibrosis, chronic pancreatitis, post-pancreatectomy, post-gastrointestinal bypass surgery, e.g. billroth ii, gastroenterostomy; ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - pancreas powder - gastro-resistant granules - 60.12 milligram(s) - enzyme preparations; multienzymes (lipase, protease etc.)

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - granules gastro-resistant - 60.12 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris healthcare limited - pancreas powder - gastro-resistant granules - enzyme preparations; multienzymes (lipase, protease etc.)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - amylase; lipase; protease - gastro-resistant granules - 3600unit ; 5000unit ; 200unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - amylase; lipase; protease - gastro-resistant granules - 3600unit ; 5000unit ; 200unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - amylase; lipase; protease - gastro-resistant granules - 3600unit ; 5000unit ; 200unit

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - pancreas powder - granules gastro-resistant - 60.12 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - pancreas powder - granules gastro-resistant - 60.36mg milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 420 mg (equivalent: lipase, qty 35000 ph eur unit; equivalent: amylase, qty 25200 ph eur unit; equivalent: protease, qty 1400 ph eur unit) - capsule - excipient ingredients: macrogol 4000; hypromellose phthalate; cetyl alcohol; triethyl citrate; dimeticone 1000; gelatin; iron oxide red; iron oxide yellow; iron oxide black; titanium dioxide; sodium lauryl sulfate - creon is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: ? cystic fibrosis ? chronic pancreatitis ? pancreatic surgery ? gastrointestinal bypass surgery (e.g. bilroth ii gastroenterostomy) ? ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)